ISTH 2021 Conference Review

In this review:
  -  Dual anticoagulation/antiplatelet for peripheral arterial disease
  -  6 weeks vs 3 months of anticoagulation for VTE in children
  -  Trends in VTE and death with COVID-19
  -  Estimating bleeding risk in CAT
  -  Predictors of lupus anticoagulant test variability and thrombotic events
  -  VWF-A1 domain binding aptamer and factor VIII half-life
  -  Oral pazopanib for hereditary haemorrhagic telangiectasia
  -  AstraZeneca vaccineinduced immune thrombotic thrombocytopenia
  -  Management of subsegmental PE without anticoagulation
  -  Brain lesion progression in antiphospholipid syndrome

Please login below to download this issue (PDF)